LFCR - LIFECORE BIOMEDICAL, INC. \DE\
6.97
0.080 1.148%
Share volume: 135,543
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$6.89
0.08
0.01%
Summary score
44%
Profitability
35%
Dept financing
42%
Liquidity
57%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-28.85%
Return on assets
-0.09%
Return on sales
-8.23%
Return on invested capital
-15.12%
Total debt ratio
78.38%
Debt ratio change over timeo
-12.24%
Current Ratio
1.79%
Quick Ratio
0.88%
Cash Position Ratio
0.11%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-2.32%
Return on sales
-18.23%
Return on invested capital
0%
Total debt ratio
97.54%
Debt ratio change over timeo
0%
Current Ratio
2.24%
Quick Ratio
1.17%
Cash Position Ratio
0.2%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-3.91%
Return on sales
-25.68%
Return on invested capital
0%
Total debt ratio
99.06%
Debt ratio change over time
0%
Current Ratio
2.71%
Quick Ratio
1.59%
Cash Position Ratio
0.17%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
72%
Return on assets
-99.45%
Return on sales
-101.77%
Return on invested capital
30.35%
Total debt ratio
-1224.18%
Debt ratio change over time
-12.24%
Current Ratio
-26.67%
Quick Ratio
-14.08%
Cash Position Ratio
-1.4%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | LFCR | LLY | JNJ | NVO |
---|---|---|---|---|
Return on equity | -28.85% | 13.23% | 9.84% | 0% |
Return on assets | -0.09% | 4.31% | 3.14% | 0% |
Return on sales | -8.23% | 28.19% | 24.65% | 0% |
Return on invested capital | -15.12% | 8.51% | 10.28% | 0% |
Profitability | 0% | 96% | 84% | 0% |
Total debt ratio | 78.38% | 80.71% | 59.43% | 0% |
Debt ratio change over time | -12.24% | -16.59% | -73.52% | 0% |
Dept financing | 24% | 25% | 18% | 25% |
Current Ratio | 2.24% | 1.26% | 1.18% | 0% |
Quick Ratio | 1.17% | 0.97% | 0.95% | 0% |
Cash Position Ratio | 0.2% | 0.11% | 0.58% | 0% |
Liquididy | 53% | 47% | 67% | 0% |
Short-term ratios | LFCR | LLY | JNJ | NVO |
---|---|---|---|---|
Return on equity | 0% | 0% | 0% | 0% |
Return on assets | -2.32% | 5.13% | 4.53% | 0% |
Return on sales | -18.23% | 33.54% | 22.07% | 0% |
Return on invested capital | 0% | 0% | 0% | 0% |
Profitability | 50% | 50% | 39% | 0% |
Total debt ratio | 97.54% | 82.17% | 59.99% | 0% |
Debt ratio change over time | 0% | 0% | 0% | 0% |
Dept financing | 50% | 21% | 15% | 0% |
Current Ratio | 2.24% | 1.26% | 1.18% | 0% |
Quick Ratio | 1.17% | 0.97% | 0.95% | 0% |
Cash Position Ratio | 0.2% | 0.11% | 0.58% | 0% |
Liquididy | 59% | 40% | 58% | 0% |